A Requirement for Cyclin-Dependent Kinase 6 in Thymocyte Development and Tumorigenesis

被引：99

作者：

Hu, Miaofen G. ^{[1
]}

Deshpande, Amit ^{[4
]}

Enos, Miriam ^{[1
]}

Mao, Daqin ^{[1
]}

Hinds, Elisabeth A. ^{[1
]}

Hu, Guo-fu ^{[2
]}

Chang, Rui ^{[1
,3
]}

Guo, Zhuyan ^{[1
,5
]}

Dose, Marei ^{[1
,6
]}

Mao, Changchuin ^{[1
]}

Tsichlis, Philip N. ^{[1
]}

Gounari, Fotini ^{[1
,6
]}

Hinds, Philip W. ^{[1
]}

机构：

[1] Tufts Med Ctr, Mol Oncol Res Inst, Boston, MA 02111 USA

[2] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA

[3] Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA

[4] Univ Calif Los Angeles, Dent Res Inst, Los Angeles, CA 90024 USA

[5] MIT, Ctr Canc Res, Dept Biol, Cambridge, MA 02139 USA

[6] Univ Chicago, Dept Med, Comm Immunol, Chicago, IL 60637 USA

来源：

CANCER RESEARCH | 2009年 / 69卷 / 03期

关键词：

T-CELL DEVELOPMENT; SIGNALING PATHWAY; GENE-EXPRESSION; NOTCH; INDUCTION; INSULIN; LINEAGE; CDK6; FATE; SUPPRESSION;

D O I：

10.1158/0008-5472.CAN-08-2473

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Cyclin-dependent kinase 6 (CDK6) promotes cell cycle progression and is overexpressed in human lymphoid malignancies. To determine the role of CDK6 in development and tumorigenesis, we generated and analyzed knockout mice. Cdk6-deficient mice show pronounced thymic atrophy due to reduced proliferative fractions and concomitant transitional blocks in the double-negative stages. Using the OP9-DL1 system to deliver temporally controlled Notch receptor-dependent signaling, we show that CDK6 is required for Notch-dependent survival, proliferation, and differentiation. Furthermore, CDK6-deficient mice were resistant to lympho-magenesis induced by active Akt, a downstream target of Notch signaling. These results show a critical requirement for CDK6 in Notch/Akt-dependent T-cell development and tumorigenesis and strongly support CDK6 as a specific therapeutic target in human lymphoid malignancies. [Cancer Res 2009; 69(3):810-8]

引用

页码：810 / 818

页数：9

共 50 条

[1] The role of cyclin-dependent kinase 6 in cardiac development and hypertrophy
Bryan, Crystal
Blanton, Robert
Aronovitz, Mark
Karas, Richard
Hu, Miaofen
Hinds, Philip W.
FASEB JOURNAL, 2013, 27
[2] Unexpected Reduction of Skin Tumorigenesis on Expression of Cyclin-Dependent Kinase 6 in Mouse Epidermis
Wang, Xian
Sistrunk, Christopher
Rodriguez-Puebla, Marcelo L.
AMERICAN JOURNAL OF PATHOLOGY, 2011, 178 (01): : 345 - 354
[3] The cyclin-dependent kinase Cdk2 regulates thymocyte apoptosis
Hakem, A
Sasaki, T
Kozieradzki, I
Penninger, JM
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (06): : 957 - 967
[4] Expression of cyclin-dependent kinase 6, but not cyclin-dependent kinase 4, alters morphology of cultured mouse astrocytes
Ericson, KK
Krull, D
Slomiany, P
Grossel, MJ
MOLECULAR CANCER RESEARCH, 2003, 1 (09) : 654 - 664
[5] Cdk pathway: Cyclin-dependent kinases and cyclin-dependent kinase inhibitors
Gitig, DM
Koff, A
MOLECULAR BIOTECHNOLOGY, 2001, 19 (02) : 179 - 188
[6] Cdk pathway: Cyclin-dependent kinases and cyclin-dependent kinase inhibitors
Diana M. Gitig
Andrew Koff
Molecular Biotechnology, 2001, 19 : 179 - 188
[7] Discovery and Development of Cyclin-Dependent Kinase 8 Inhibitors
Lv, Xiao
Tian, Yongbing
Li, Shiyu
Cheng, Kai
Huang, Xufeng
Kong, Haiyan
Liao, Chenzhong
Xie, Zhouling
CURRENT MEDICINAL CHEMISTRY, 2020, 27 (32) : 5429 - 5443
[8] Preclinical and clinical development of cyclin-dependent kinase modulators
Senderowicz, AM
Sausville, EA
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (05): : 376 - 387
[9] Complexities in the development of cyclin-dependent kinase inhibitor drugs
Sausville, EA
TRENDS IN MOLECULAR MEDICINE, 2002, 8 (04) : S32 - S37
[10] ROLE OF THE CYCLIN-DEPENDENT KINASE INHIBITORS IN THE DEVELOPMENT OF CANCER
HIRAMA, T
KOEFFLER, HP
BLOOD, 1995, 86 (03) : 841 - 854

← 1 2 3 4 5 →